The thyroid as a model for molecular mechanisms in genetic diseases;La tiroides como modelo de mecanismos moleculares en enfermedades geneticas

Medicina

Volumn 65, Issue 3, 2005, Pages 257-267

  Rivolta, Carina M ^a   Moya, Christian M ^a   Esperante, Sebastián A ^a   Gutnisky, Viviana J ^a   Varela, Viviana ^a   Targovnik, Héctor M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Gene; Hypothyroidism; Mutation; Thyroid; Thyroid diseases

Indexed keywords

PENDRIN; SODIUM IODIDE SYMPORTER; THYROGLOBULIN; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROID PEROXIDASE; THYROID TRANSCRIPTION FACTOR 1; THYROID TRANSCRIPTION FACTOR 2; THYROTROPIN; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR PAX8;

AGENESIS; AUTOSOMAL RECESSIVE INHERITANCE; CONGENITAL HYPOTHYROIDISM; EMBRYO DEVELOPMENT; GENE MUTATION; GENETIC DISORDER; GOITER; HORMONE ACTION; HUMAN; HYPOPLASIA; MOLECULAR MECHANICS; PREVALENCE; REVIEW; THYROID ADENOMA; THYROID DISEASE; THYROID HORMONE RESISTANCE; THYROID HORMONE SYNTHESIS; WILD TYPE;

CONGENITAL HYPOTHYROIDISM; GOITER; HUMANS; HYPERTHYROIDISM; IODIDE PEROXIDASE; MUTATION; RECEPTORS, THYROTROPIN; THYROID HORMONES;

EID: 21844435472     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Pendred V. Deaf mutism and goiter. Lancet 1896; 2:532.
2. Osler W. Sporadic cretinism in America. Trans Congress Am Physicians Surg 1897; 4: 169-206.
3. Stanbury J, Chapman E. Congenital hypothyroidism with goiter: absence of an iodide-concentring mechanism. Lancet 1960; 1: 1162-5.
4. Stanbury J, Hedge A. A study of a family of goitrous cretins. J Clin Endocrinol Metab 1950; 10: 1471-5.
5. Medeiros-Neto G, Knobel M, DeGroot LJ. Genetic disorders of the thyroid hormone system. In: Baxter JD, (eds). Genetics in Endocrinology. Philadelphia: Lippincott, Williams and Wilkins, 2002, p 375-402.
6. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379: 458-60.
7. Coyle B, Coffey R, Armour JAL, et al. Pendred syndrome (goitre and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4. Nat Genet 1996; 12: 421-6.
8. Sheffield VC, Kraiem Z, Beck JC et al. Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification. Nat Genet 1996; 12: 424-6.
9. Parmentier M, Libert F, Maenhaut C, et al. Molecular cloning of the thyrotropin receptor. Science 1989; 246: 1620-2.
10. Damonte G, Di Lauro R. Thyroid-specific gene expression. Biochim Biophys Acta 1994; 1218: 255-66.
11. Hamdan H, Liu H, Li C, et al. Structure of the human NKX2.1 gene. Biochim Biophys Acta 1998; 1396: 336-48.
12. Chadwick BP, Obermayr F, Frischauf AM. FKHL15, a new human member of the forkhead gene family located on chromosome 9q22. Genomics 1997; 41: 390-6.
13. Zannini M, Avantaggiato V, Biffali E, et al. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 1997; 16: 3185-97.
14. Poleev A, Fickenscher H, Mundlos S, et al. PAX 8, a human paired box gene: isolation and expression in the developing thyroid, kidney and Wilms' tumors. Development 1992; 116: 611-23.
15. Rabin M, Barker P E, Ruddle F H, Brocas H, Targovnik H, Vassart G. Proximity of thyroglobulin and c-myc genes on human chromosome 8. Somatic Cell Mol Genet 1985; 11: 397-402.
16. Targovnik HM, Pohl V, Christophe D, Cabrer B, Brocas H, Vassart G. Structural organization of the 5′ region of the human thyroglobulin gene. Eur J Biochem 1984; 141: 271-7.
17. Mendive FM, Rivolta CM, Vassart G, Targovnik HM. Genomic organization of the 3′ region of the human thyroglobulin gene. Thyroid 1999; 9: 903-12.
18. Moya CM, Mendive FM, Rivolta CM, Vassart G, Targovnik HM. Genomic organization of the 5′ region of the human thyroglobulin gene. Eur J Endocrinol 2000; 143: 789-98.
19. Mendive FM, Rivolta CM, Moya CM, Vassart G, Targovnik HM. Genomic organization of the human thyroglobulin gene. The complete intron-exon structure. Eur J Endocrinol 2001; 145: 485-96.
20. van de Graaf SAR, Ris-Stalpers C, Pauws E, Mendive FM, Targovnik HM, de Vijlder JJM. Up to date with human thyroglobulin. J Endocrinol 2001; 170: 307-21.
21. Moya CM, Varela V, Rivolta CM, Mendive FM, Targovnik HM. Identification and characterization of a novel large insertion/deletion polymorphism of 1464 base pair in the human thyroglobulin gene. Thyroid 2003; 13: 319-23.
22. Rivolta CM, Moya CM, Mendive FM, Targovnik HM Genotyping and characterization of two polymorphic microsatellite markers located within introns 29 and 30 of the human thyroglobulin gene. Thyroid 2002; 12: 773-9.
23. Mendive FM, Rossetti LC, Vassart G, Targovnik HM. Identification of a new thyroglobulin variant: A guanine-to-adenine transition resulting in the substitution of arginine 2510 by glutamine. Thyroid 1997; 7: 587-91.
24. Molina F, Pau B, Granier C. The type-1 repeats of thyroglobulin regulate thyroglobulin degradation and T3, T4 release in thyrocytes. FEBS Letters 1996; 391: 229-31.
25. Medeiros-Neto G, Kim PS, Yoo SE et al. Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 1996; 98: 2838-44.
26. Ulianich L, Suzuki K, Mori A, et al. Follicular thyroglobulin (TG) suppression of thyroid-restricted genes involves the apical membrane asialoglycoprotein receptor and TG phosphorylation. J Biol Chem 1999; 274: 25099-107.
27. Marino M, Zheng G, Chiovato L, et al. Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novelfunction in the control of thyroid hormone release. J Biol Chem 2000; 275: 7125-37.
28. Metzghrani A, Courageot J, Mani JC, Pugniere M, Bastiani P, Miquelis R. Protein- disulfide Isomerase (PDI) in FRTL5 cells. PH-dependet thyroglobulin/PDI interactions determine a novel PDI function in the post-endoplasmic reticulum of thyrocytes. J Biol Chem 2000; 275: 1920-9.
29. Kimura S, Hong Y-S, Kotani T, Othaki S, Kikkawa F. Structure of the human thyroid peroxidase gene: comparison and relationship to the human myeloperoxidase gene. Biochemistry 1989; 28: 4481-9.
30. De Deken X, Wang D, Many MC, et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 2000; 275: 23227-33.
31. Morand S, Agnandji D, Noel-Hudson MS, et al. Targeting of the dual oxidase 2 N-terminal region to the plasma membrane. J Biol Chem 2004; 279: 30244-51.
32. Kopp P. Perspective: genetic defects in the etiology of congenital hypothyroidism. Endocrinology 2002; 143: 2019-24.
33. Pohlenz J, Dumitrescu A, Zundel D, et al. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest 2002; 109: 469-73.
34. Krude H, Schütz B, Biebermann H, et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002; 109: 475-80.
35. Clifton-Bligh R J, Wentworth J M, Heinz P, et al. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 1998; 19: 399-401.
36. Macchia PE, Lapi P, Krude H, et al. PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet 1998; 19: 83-6.
37. Vilain C, Rydlewski C, Duprez L, et al. Autosomal dominant trasmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8. J Clin Endo-crinol Metab 2001; 86: 234-8.
38. Congdon T, Nguyen LQ, Nogueira CR, Habiby RL, Medeiros-Neto G, Kopp P. A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: Evidence for phenotypic variability in mother and child. J Clin Endocrinol Metab 2001; 86: 3962-7.
39. Meeus L, Gilbert B, Rydlewski C, et al. Characterization of a novel loss of function mutation of PAX8 in a familial case of congenital hypothyroidism with in-place, normal-sized thyroid. J Clin Endocrinol Metab 2004; 89: 4285-91.
40. Sunthornthepvarakul T, Gottschalk M E, Hayashi Y, Refetoff S. Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 1995; 332: 155-160.
41. Tonacchera M, Van Sande J, Parma J, et al. TSH receptor and disease. Clin Endocrinol 1996; 44: 621-33.
42. Refetoff S. Clinical features and molecular basis of thyrotrophin resistance. Topical Endocrinol 1996; 4: 9-12.
43. Abramowicz MJ, Duprez L, Parma J, Vassart G, Heinrichs C. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 1997; 99: 3018-24.
44. Tonacchera M, Agretti P, Pinchera A, et al. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene. J Clin Endocrinol Metab 2000; 85: 1001-8.
45. Parma J, Duprez L, Van Sande J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365: 649-51.
46. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 1994; 79: 1785-9.
47. Duprez L, Parma J, Van Sande J, et al. Germline mutations in the thyrotropin receptor gene cause non autoimmune autosomal dominant hyperthyroidism. Nat Genet 1994; 7: 396-401.
48. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 1995; 80: 2577-85.
49. 2+ cascades. Mol Endocrinolo 1995; 9: 725-33.
50. Kopp P, Van Sande J, Parma J, et al. Congenital hyperthyroidism caused by a mutation in the thyrotropin receptor gene. N Engl J Med 1995; 332: 150-4.
51. Leclere J F, Vassart G. Hyperthyroidism due to mutations that constitutively activate thyrotrophin receptors. Topical Endocrinol 1996; 4: 5-8.
52. Vassart G, Van Sande J, Parma J, et al. Activating mutations of the TSH receptor gene cause thyroid diseases. An Endocrinol (Paris) 1996; 57: 50-4.
53. Tonacchera M, Van Sande J, Cetani F, et al. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 1996; 81: 547-54.
54. Duprez L, Hermans J, Van Sande J, Dumont JE, Vassart G, Parma J. Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. J Clin Endocrinol Metab 1997; 82: 306-8.
55. Pohlenz J, Dumitrescu A, Aumann U, et al. Congenital secondary hypothiroidism caused by exon skipping due to a homozygous donor splice site mutation in the TSHb-subunit gene. J Clin Endocrinol Metab 2002; 87: 336-9.
56. Borck G, Topaloglu AK, Korsch E, et al. Four cases of congenital secondary hypothyroidism due to a splice site mutation in the thyrotropin-b gene: Phenotypic Variability and founder effect. J Clin Endocrinol Metab 2004; 89: 4136-41.
57. Ieiri T, Cochaux P, Targovnik HM, et al. A 3′ splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 1991; 88: 1901-5.
58. Targovnik HM, Medeiros-Neto G, Varela V, Cochaux P, Wajchenberg BL, Vassart G. A nonsense mutation causes human hereditary congenital goiter with preferential production of a 171-nucleotide-deleted thyroglobulin ribonucleic acid messenger. J Clin Endocrinol Metab 1993; 77: 210-5.
59. Medeiros-Neto G, Targovnik HM, Vassart G. Defective thyroglobulin synthesis and secretion causing goiter and hypothyroidism. Endocr Rev 1993; 14: 165-83.
60. van de Graaf SAR, Ris-Stalpers C, Veenboer GJM, et al. A premature stopcodon in thyroglobulin mRNA results in familial goiter and moderate hypothyroidism. J Clin Endocrinol Metab 1999; 84: 2537-42.
61. Targovnik HM, Rivolta CM, Mendive FM, Moya CM, Medeiros-Neto G. Congenital goiter with hypothyroidism caused by a 5′ Splice Site mutation in the thyroglobulin gene. Thyroid 2001; 11: 685-90.
62. Caron P, Moya CM, Malet D, et al. Compound heterozygous mutations in the thyroglobulin gene (1143delC and 6725G→A[R2223H]) resulting in fetal goitrous hypothyroidism. J Clin Endocrinol Metab 2003; 88: 3546-53.
63. Gutnisky VJ, Moya CM, Rivolta CM, et al. Two distinct compound heterozygous constellation (R277X/IVS34-1G>C and R277X /R1511X) in the thyroglobulin (TG) gene in affected individuals of a brazilian kindred with congenital goiter and defective TG synthesis. J Clin Endocrinol Metab 2004; 89: 646-57.
64. Abramowicz MJ, Targovnik HM, Varela V, et al. Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest 1992, 90: 1200-4.
65. Medeiros-Neto GA, Billerbeck AEC, Wajchenberg BL, Targovnik HM. Defective organification of iodide causing hereditary goitrous-hypothyroidism. Thyroid 1993; 3: 143-159.
66. Bikker H, den Hartog MT, Baas F, Gons MH, Vulsma T, de Vijlder JJM. A 20 basepair duplication in the human thyroid peroxidase gene results in a total iodide organification defect and congenital hypothyroidism. J Clin Endocrinol Metab 1994; 79: 248-52.
67. Bikker H, Vulsma T, Baas F, de Vijlder JJM. Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturating gradient gel electrophoresis. Hum Mutat 1995; 6: 9-16.
68. Bikker H, Waelkens JJJ, Bravenboer B, de Vijlder JJM. Congenital hypothyroidism caused by a premature termination signal in exon 10 of the human thyroid peroxidase gene. J Clin Endocrinol Metab 1996; 81: 2076-9.
69. Kotani T, Urneki K, Yamamoto I, Maesaka H, Tachibana K, Ohtaki S. A novel mutation in the human thyroid peroxidase gene resulting in a total iodide organification defect. J Endocrinol 1999; 160: 267-73.
70. Pannain S, Weiss RE, Jackson CE, et al. Two different mutations in the thyroid peroxidase gene of a large inbred Amish kindred: power and limits of homozygosity mapping. J Clin Endocrinol Metab 1999; 84: 1061-71.
71. Santos CLS, Bikker H, Rego KGM, et al. A novel mutation in the TPO gene in goitrous hypothyroid patients with iodide organification defect. Clin Endocrinol 1999; 51: 165-172.
72. Bakker B, Bikker H, Vulsma T, de Randamie JSE, Wiedijk BM, de Vijlder JJM. Two decades of screening for congenital hypothyroidism in the Netherlands: TPO gene mutations in total iodide organification defect (an update). J Clin Endocrinol Metab 2000; 85: 3708-12.
73. Ambrugger P, Stoeva I, Biebermann H, Torresani T, Leitner C, Grüters A. Novel mutations of the thyroid peroxidase gene in patients with permanent congenital hypothyroidism. Eur J Endocrinol 2001; 145: 19-24.
74. Bakker B, Bikker H, Hennekam RCM, et al. Maternal isodisomy for chromosome 2p causing severe congenital hypothyroidism. J Clin Endocrinol Metab 2001; 86: 1164-8.
75. Kotani T, Umeki K, Yamamoto I, Ohtaki S, Adachi M, Tachibana K. Iodide organification defects resulting from cosegregation of mutated and null thyroid peroxidase alleles. Mol Cell Endocrinol 2001; 182: 61-8.
76. Niu DM, Hwang B, Chu YK, Liao CJ, Wang PL, Lin CY. High prevalence of a novel mutation (2268 insT) of the thyroid peroxidase gene in Taiwanese patients with total iodide organification defect, and evidence for a founder effect. J Clin Endocrinol Metab 2002; 87: 4208-12.
77. Umeki K, Kotani T, Kawano JI, et al. Two novel missense mutations in the thyroid peroxidase gene: R665W and G771R result in a localization defect and cause congenital hypothyroidism. Eur J Endocrinol 2002; 146: 491-8.
78. Wu JY, Shu SG, Yang CF, Lee CC, Tsai FJ. Mutation analysis of thyroid peroxidase gene Chinese patients with total iodide organification defect: identification of five novel mutations. J Endocrinol 2002; 172: 627-35.
79. Rivolta CM, Esperante SA, Gruñeiro-Papendick L, et al. Five novel inactivating mutations in the human thyroid peroxidase gene responsible for congenital goiter and iodide organification defect. Human Mutation 2003; 22: 259.
80. Moreno JC, Bikker H, Kempers MJE, et al. Inactiving mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002; 347: 95-102.
81. Miki K, Harada T, Miyai K, Takai SI, Amino N. Congenital hypothyroidism caused by a mutation in the Na+/I-symporter. Nat Genet 1997; 16: 124-5.
82. Pohlenz J, Medeiros-Neto G, Gross J L, Silveiro S P, Knobel M, Refetoff S. Hypothyroidism in a brazilian kindred due to iodide trapping defect caused by homozygous mutation in the sodium/iodide symporter gene. Biochem Biophys Res Commun 1997; 240: 488-91.
83. Pohlenz J, Rosenthal IM, Weiss RE, Jhiang SM, Burant C, Refetoff S. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3′ splice site. J Clin Invest 1998; 101: 1028-35.
84. Kopp P. Pendred syndrome and genetic defects in thyroid hormone synthesis. Reviews Endocr Metab Dis 2000; 1: 109-121.
85. Borck G, Roth C, Martiné U, Wildhardt G, Pohlenz J. Mutations in the PDS gene in German families with Pendred's syndrome: V138F is a founder mutation. J Clin Endocrinol Metab 2003; 88: 2916-21.
86. Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev 1993; 14: 348-99.
87. Kopp P, Kitajima K, Jameson JL. Syndrome of resistance to thyroid hormone: insights into thyroid hormone action. Proc Soc Exp Biol Med 1996; 211:49-61.
88. Weiss R E, Refetoff S. Resistance to thyroid hormone Rev Endocr Metab Disord Jan 2000; 1: 97-108.
89. Sakurai A, Nakai A, DeGroot LJ. Structural analysis of human thyroid receptor β gene. Mol Cel Endocrinol 1990; 71: 83-91.
90. Weiss RE, Stein MA, Duck SC, et al. Low intelligence but not attention deficit hyperactivity disorder is associated with resistance to thyroid hormone caused by mutation R316H in the thyroid hormone receptor β gene. J Clin Endocrinol Metab 1994; 78: 1525-8.
91. Refetoff S, Weiss RE, Wing JR, Sarne D, Chyna B, Hayashi Y. Resistance to thyroid hormone in subjects from two unrelated families is associated with a point mutation in the thyroid hormone receptor β gene resulting in the replacement of the normal proline 453 with serine. Thyroid 1994; 4: 249-54.
92. Weiss R E, Chyna B, Duell PB, Hayashi Y, Sunthornthepvarakul T, Refetoff S. A new point mutation (C446R) in the thyroid hormone receptor-beta gene of a family with resistance to thyroid hormone. J Clin Endocr Metab 1994; 78: 1253-6.
93. Brucker-Davis F, Skarulis MC, Grace MB, et al. Genetic and clinical features of 42 kindred with resistance to thyroid hormone. Ann Int Med 1995; 123: 572-83.
94. Weiss RE, Tunca H, Gerstein H C, Refetoff S. A new mutation in the thyroid hormone receptor (TR) beta gene (V458A) in a family with resistance to thyroid hormone (RTH). Thyroid 1996; 6: 311-2.
95. Pohlenz J, Schönberger W, Wemme H, Winterpacht A, Wirth S, Zabel B. New point mutation (R243W) in the hormone binding domain of the c-erbA β-1 gene in a family with generalized resistance to thyroid hormone. Hum Mutat 1996; 7: 79-81.
96. Yagi H, Pohlenz J, Hayashi Y, Sakurai A, Refetoff S. Resistance to thyroid hormone caused by two mutant thyroid hormone receptor β, R243Q and R243W, with marked impairment of function that cannot be explained by altered in-vitro 3,5,3′-triiodothyronine binding affinity. J Clin Endocrinol Metab 1997; 82: 1608-14.
97. Di Fulvio M, Chiesa A, Baranzini S, Gruñiero-Papendieck L, Masini-Repiso A, Targovnik H. A new point mutation (M313T) in the thyroid hormone receptor β gene in a patient with resistance to thyroid hormone. Thyroid 1997; 7: 43-4.
98. Nagashima T, Yagi H, Nagashima K, et al. A novel point mutation of thyroid hormone receptor β gene in a family with resistance to thyroid hormone. Thyroid 1997; 7: 771-3.
99. Clifton-Bligh RJ, de Zegher F, Wagner RL, et al. A novel TR β mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation. Mol Endocrinol 1998; 12: 609-21.
100. Menzaghi C, Balsamo A, Di Paola R, et al. Association between an R338L mutation in the thyroid hormone receptor-β gene and thyrotoxic features in two unrelated kindreds with resistance to thyroid hormone. Thyroid 1999; 9: 1-6.
101. Sarkissian G, Dace A, Mesmacque A, et al. A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor β gene. Thyroid 1999; 9: 165-171.
102. Furlanetto TW, Kopp P, Peccin S, Gu WX, Jameson JL. A novel mutation (M310L) in the thyroid hormone receptor β causing resistance to thyroid hormone in a brazilian kindred and a neonate. Mol Genet Metab 2000; 71: 520-6.
103. Phillips SA, Rotman-Pikielny P, Lazar J, et al. Extreme thyroid hormone resistance in a patient with a novel truncated TR mutant. J Clin Endocrinol Metab 2001; 86: 5142-7.
104. Rivolta CM, Feijoo MC, Targovnik HM, Funes A. Identificación de una transversión heterocigota 1357C>A (P453T) en el exón 10 del gen del receptor de hormonas tiroideas β en una familia con resistencia a hormonas tiroideas. Rev Argent Endocrinol Metab 2003; 40: 13-22.
105. Rivolta CM, Herzovich V, Esperante SA, Lazzati JM, Iorcansky S, Targovnik H M. Identificación de una transición heterocigota 1012C>T (R338W) en el exón 9 del gen del receptor β de hormonas tiroideas en una familia con resistencia generalizada a hormonas tiroideas. Rev Argent Endocrinol Metab 2003; 40: 165-71.
106. Rivolta CM, Mallea Gil MS, Ballarino C, et al. A novel 1297-1304delGCCTGCCA mutation in the exon 10 of the thyroid hormone receptor β gene causes resistance to thyroid hormone. Mol Diagn 2004; 8: 163-9.